FDA panel backs black box alert for ADHD drugs.(Food and Drug Administration)(Attention deficit hyperactivity disorder)

From: Internal Medicine News | Date: March 15, 2006| Author: Mechcatie, Elizabeth | Copyright information

GAITHERSBURG, MD. -- The Food and Drug Administration is considering how best to inform physicians, adults with attention-deficit hyperactivity disorder, and parents of children with ADHD about the potential cardiovascular risks of the drugs used to treat the disorder.

At a meeting last month, the FDA's Drug Safety and Risk Management Advisory Committee voted 8 to 7 in favor of adding a black box warning to the label of ADHD drugs to alert physicians and the public that ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

FDA panel backs stronger warnings on ADHD drugs; voted 8-7 to add black box on cardio risks.(attention-deficit hyperactivity disorder)
Family Practice News ; GAITHERSBURG, MD. -- The best way to inform physicians, adults with attention-deficit hyperactivity disorder, and parents of children with ADHD about the potential cardiovascular risks of the drugs used to treat the disorder is under consideration at the Food and Drug Administration. At a meeting
Black Box initiative for ADHD drugs stirs controversy: panel proposes, official opposes warning.(News)
Pediatric News ; GAITHERSBURG, MD. -- The best way to inform physicians and the public about potential cardiovascular risks of drugs used to treat attention-deficit hyperactivity disorder is to conduct a trial rather than add a black box warning to the labels of those drugs at this point, an FDA official says. The
Federal study to probe heart risk in ADHD drugs.(Mental Health)
Family Practice News ; Officials at the Food and Drug Administration and the Agency for Healthcare Research and Quality are launching a large-scale study to determine whether the medications used to treat attention-deficit hyperactivity disorder expose patients to an increased risk for cardiovascular problems. The study
Support for sudden death.(Life)
The Mercury (South Africa) ; ARRHYTHMIA, or sudden death, is a sudden cardiac arrest that occurs when the electricity of the heart malfunctions. The heart then collapses. Often confused with a heart attack, the condition is not brought on by blocked arteries and does not necessarily manifest with chest pains. Most disturbing
Federal study to look at ADHD drugs, possible heart risks.(News)
Clinical Psychiatry News ; Officials at the Food and Drug Administration and the Agency for Healthcare Research and Quality are launching a largescale study aimed at determining whether the medications used to treat attention-deficit/hyperactivity disorder expose patients to an increased risk for cardiovascular problems. The